Paul Giannasca

Nessuna posizione attualmente

60 anni

Health Technology

Consumer Services

Profilo

Paul Giannasca worked as a Scientist at OraVax, Inc. and as Vice President-Development at Acambis Plc and Genocea Biosciences, Inc. He obtained an undergraduate degree from Fairleigh Dickinson University and a doctorate degree from the University of Massachusetts.

Precedenti posizioni note di Paul Giannasca

Società	Posizione	Fine
OraVax, Inc. OraVax, Inc. BiotechnologyHealth Technology Part of Sanofi, OraVax, Inc. is a company that has a slick name that taps into the words 'oral' and 'vaccine' in a subtle way. The company is based in Cambridge, MA. The company is a possible oral health brand, medical licensing service, app, or chemicals company. OraVax was acquired by Acambis Plc, part of Sanofi from September 22, 2008 on May 11, 1999 for $17.79 million.	Corporate Officer/Principal	-
GENOCEA BIOSCIENCES, INC.	Corporate Officer/Principal	-
Acambis Plc Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Paul Giannasca

Formazione di Paul Giannasca

Fairleigh Dickinson University	Undergraduate Degree
University of Massachusetts	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private